Floxil

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Floxil

Property Description
Active ingredient Ofloxacin (INN)
Form Oral tablet, Ophthalmic solution, IV injection
Pharmacological class Fluoroquinolone Antibiotic
Common use Combating bacterial proliferation
Origin Synthetic

What is Ofloxacin and What Class of Medicine is Floxil?

Floxil is a common trade name for the drug Ofloxacin, which is formally classified as a synthetic, broad-spectrum antibiotic used to combat bacterial proliferation. This medication belongs to the fluoroquinolone class of antimicrobial agents, representing a second-generation compound within this category. The drug is prescription-only (Rx), underscoring its potency and the need for medical oversight during use, a factor associated with strong antimicrobial agents.


The core active ingredient is Ofloxacin (INN), a purely synthetic small molecule that acts as a single-ingredient product. It is chemically defined as a fluorinated carboxyquinolone compound. Understanding this classification is crucial, as it identifies Ofloxacin as a powerful agent whose function is to eliminate bacterial proliferation within the body. The substance is a racemic mixture containing both active and less active forms, a characteristic that differentiates it from its pure, single-isomer counterpart, levofloxacin, and serves as a key differentiating factor.


Ofloxacin's Fundamental Purpose and Available Forms

The fundamental purpose of Ofloxacin is derived from its bactericidal effect, meaning it actively kills susceptible bacteria by disrupting their critical genetic processes. This mechanism defines its overall benefit: to resolve various illnesses caused by invading microbes, such as addressing bacterial issues like a middle ear infection.


To facilitate treatment across different sites in the body, Ofloxacin is manufactured in multiple dosage forms. The drug is available as an oral tablet for internal systemic administration, as an intravenous injection solution typically used in hospital settings for serious systemic issues, and as an ophthalmic solution (drops) intended for topical use to target bacterial infections of the eye. This variety of preparations ensures effective delivery of the active ingredient to address either widespread or localized bacterial threats, utilizing a strategy for targeted anti-infective efficacy.

Regulatory References

  1. Ofloxacin - StatPearls - NCBI Bookshelf

What side effects are possible with Floxil?

Possible side effects and safety information: Floxil

The safety profile of Floxil (ofloxacin), a systemic fluoroquinolone antibiotic, is documented by regulatory authorities through specific classifications of adverse reactions, organ-system effects, and safety constraints. The official labeling outlines common, uncommon, and rare side effects, organized by the body system affected.

Adverse Reaction Classifications

Side effects commonly reported in regulatory sources include Gastrointestinal disturbances such as nausea, diarrhea, and vomiting, as well as Nervous System effects like headache and insomnia. Uncommon reactions involve dizziness, rash, and pruritus. Rarer, but serious, documented effects include psychotic disorders, convulsions, and Tendinitis.

Serious Adverse Reactions

Official safety communications highlight the risk of disabling and potentially irreversible serious adverse reactions associated with systemic fluoroquinolones. These include Tendon Rupture (often the Achilles tendon), Peripheral Neuropathy (which can be long-lasting), and serious Central Nervous System effects like hallucinations and suicidal ideation. Furthermore, the label notes risks of Aortic Aneurysm and Dissection and serious cardiovascular effects like QT interval prolongation and Torsades de pointes.

Safety Considerations and Timing

Safety constraints are documented for specific populations. Older adults (over 60 years) have an increased risk of tendon injury. Caution is required for diabetic patients due to the risk of blood sugar changes (dysglycemia) and for patients with a history of Myasthenia Gravis. Regulatory information indicates that serious effects like tendon rupture can occur within 48 hours of starting treatment or up to several months after discontinuation.

Overdose and Emergency Response

Overdose and When to Seek Help

This information is based strictly on the officially documented overdose profile for ofloxacin (Floxil/FLOXIN) as detailed in regulatory prescribing information.

Required Emergency Action

Immediately contact a poison control center or seek emergency medical attention if an overdosage is suspected.

Documented Manifestations

Acute overdosage is typically expected to lead to an exacerbation of documented adverse reactions, particularly those affecting the Central Nervous System (CNS). The symptoms officially documented in regulatory sources include:

  • Drowsiness
  • Dizziness
  • Nausea
  • Confusion
  • Slurred speech
  • Numbness and swelling of the face

Overdose Management

Official regulatory guidance confirms that management of an overdose is primarily supportive and symptomatic.

Management Factor Official Statement
Specific Antidote No specific antidote is available.
Drug Elimination Ofloxacin is not efficiently removed from the body by hemodialysis or peritoneal dialysis.
First Measures Employ appropriate treatment such as gastric lavage and symptomatic observation.

All cases of suspected overdose require professional medical evaluation and management.

Therapeutic Uses of Floxil

Quick Facts: Floxil Therapeutic Uses

  • Addresses: Acute bacterial exacerbation of chronic bronchitis (ABECB) in certain patients.
  • Addresses: Community-acquired pneumonia (CAP).
  • Addresses: Infections of the skin and skin structure.
  • Addresses: Certain infections of the urinary tract and prostate.
  • Addresses: Acute pelvic inflammatory disease and some sexually transmitted infections.

What Floxil Treats: Main Uses and Benefits

Floxil (ofloxacin) is a prescription medicine authorized for the management of specific bacterial infections in adults. Its primary therapeutic application involves acting on the bacteria that may cause various conditions throughout the body.

The medication is utilized in cases of certain lower respiratory tract infections, including community-acquired pneumonia and select instances of acute bacterial exacerbation of chronic bronchitis (ABECB) where other treatments are not suitable. It provides support for the resolution of uncomplicated skin and skin structure infections, as well as specific infections of the urinary system, such as complicated urinary tract infections and prostatitis.

Floxil is also an option in the therapeutic domain of certain sexually transmitted infections, including acute pelvic inflammatory disease (PID) and infections of the cervix and urethra. Treatment with Floxil aims to assist in the improvement of the targeted condition.

Eligibility and Restrictions for Use

Floxil (ofloxacin) is subject to strict eligibility rules defined by regulatory authorities to ensure population safety. Systemic use (oral or intravenous) is absolutely contraindicated for patients with a documented history of hypersensitivity to Ofloxacin or any other fluoroquinolone antibiotic. Use is also prohibited for individuals with certain central nervous system disorders, including a history of epilepsy, or a history of tendon disorders related to prior quinolone exposure.

Regarding age, systemic Ofloxacin is contraindicated in children and growing adolescents. Eligibility for systemic use is reserved for adults (ge 18 years). Conversely, the topical otic solution formulation is established as safe for use in pediatric patients starting at six months of age. Systemic Ofloxacin is also not recommended or contraindicated for women who are pregnant or breastfeeding.

Furthermore, conditional eligibility applies to patients with impaired renal function, requiring a mandatory dosage adjustment as defined by the label. Specific caution is mandated for individuals with Myasthenia Gravis, risk factors for QT prolongation, or those who are organ transplant recipients.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Floxil (ofloxacin) has documented interactions with several classes of medicinal products, requiring specific management or avoidance based on official regulatory labeling.

Documented Interaction Categories

Interacting Product Category Interaction Consequence Constraint/Classification
Metal Cation-Containing Products (e.g., Antacids, Sucralfate, Iron/Zinc Supplements) Significantly reduced absorption of Floxil via chelation, lowering systemic concentrations. Administration must be separated, typically by at least two hours.
Corticosteroids (Oral or Injectable) Increased risk of severe tendon disorders (e.g., tendon rupture). Concomitant use is generally advised against due to heightened risk.
Antiarrhythmics (Class IA and III) and other QT-Prolonging Drugs Increased risk of cardiac arrhythmias. Use with caution; monitoring is recommended.
Theophylline Elevated plasma concentrations of Theophylline. Requires monitoring of Theophylline levels and potential dose reduction.
Warfarin Increased anticoagulant effect, raising the risk of bleeding. Requires close and frequent monitoring of INR (International Normalized Ratio).
Antidiabetic Agents (e.g., Insulin, Oral Hypoglycemics) Risk of blood glucose disturbances (hypoglycemia or hyperglycemia). Requires close monitoring of blood glucose levels.

This interaction profile is defined by official regulatory documentation to ensure safe product use. The critical constraint involves the physical need to separate Floxil administration from polyvalent cation products to maintain effective absorption. Furthermore, the profile highlights specific pharmacodynamic risks, such as the major interaction with corticosteroids concerning tendon safety, and the need for intense monitoring with agents like Warfarin and antidiabetic drugs.

Mechanism of Action

The mechanism of action for Floxil (Ofloxacin) involves a process that results in microbial cell death by interfering with the enzymatic systems essential for bacterial DNA management.


Targeted Inhibition of Bacterial DNA Enzymes

Ofloxacin penetrates the bacterial cell and acts as a specific inhibitor of two enzymes: DNA Gyrase (Topoisomerase II) and Topoisomerase IV . These enzymes manage the winding, unwinding, and separation of the bacterial chromosome. The drug exhibits selective toxicity for these bacterial forms compared to analogous human enzymes.


Cascade of Irreversible Genetic Damage

By binding to the DNA-enzyme complex, Ofloxacin prevents the necessary re-ligation of DNA strands, stabilizing a lethal intermediate state. This molecular failure causes the rapid accumulation of irreversible double-stranded DNA breaks, resulting in the physiological effect of microbial cell death (bactericidal action).


Mechanisms of Resistance and Constraints

The mechanistic activity is constrained if bacteria develop genetic mutations in the target enzymes (gyrA, parC), which reduce Ofloxacin's binding affinity. The mechanism's influence is also reduced if bacteria overexpress efflux pumps, which actively transport the drug out of the cell, lowering the concentration available for enzyme inhibition.

Dosage and Administration Information

How to Use Floxil

Floxil, which contains the active ingredient ofloxacin, is administered through strictly defined routes and schedules. The medication is available for oral (tablets), intravenous (IV) infusion, and topical ophthalmic administration, with the route chosen based on the prescribed formulation.

Dosing and Scheduling Principles

The standard adult systemic dosage typically ranges from 200 mg to a maximum of 800 mg per day. Most oral regimens are administered twice daily (every 12 hours) to maintain adequate systemic concentration. However, a total daily dose of 400 mg or less may be administered as a single, once-daily dose. The duration of use is highly variable, ranging from short courses of 3 days for certain uncomplicated urinary infections up to 6 weeks for conditions like prostatitis.

Administration Conditions

Oral tablets may be taken with or without food; absorption is not significantly affected by meals. A critical administration requirement specifies that oral ofloxacin must be taken two hours before or two hours after consuming preparations that contain multivalent cations, such as mineral antacids (aluminum/magnesium), sucralfate, iron, or zinc supplements, to prevent interference with drug uptake.

For the intravenous route, the drug is administered via infusion. Dosage adjustment is mandatory for patients with significantly reduced kidney function (creatinine clearance le 50 mL/min), requiring a reduction in the maintenance dose or an extension of the dosing interval.

Recent Clinical Evidence

Research evidence / Overview of studies for Floxil

Overview of the Research Landscape for Floxil

The clinical evaluation of Floxil (ofloxacin) has primarily relied on Randomized Controlled Trials (RCTs) and various comparative studies conducted across multiple centers. These studies were used in the research context to examine how Ofloxacin was studied in comparison to either a placebo or other standard antibiotic treatments for specific types of bacterial infections. The core evidence for Ofloxacin was derived from trials conducted prior to the widespread use of certain later-developed antibiotic agents, and the study findings are cited in the regulatory documents that govern the medicine's approved uses.


Evidence for Use in Respiratory Tract Infections

Research examined Ofloxacin for use in patients with Community-Acquired Pneumonia (CAP) and those experiencing an Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). The studies were designed to monitor outcomes related to physical discomfort and systemic or functional imbalance caused by these conditions involving periods of heightened symptoms.

For CAP, short-term RCTs and systematic reviews were applied in studies examining patient-reported experiences and clinical status in both outpatient and hospitalized adults. Research describes patterns observed in the studies that measured clinical cure rates. However, evidence quality varies across studies, and some larger analyses have indicated that findings were mixed, particularly when looking at differences in high-level patient outcomes.


Evidence for Use in Urinary and Reproductive Tract Infections

Research has extensively explored Ofloxacin's use in Complicated Urinary Tract Infections (cUTI) and Acute Pelvic Inflammatory Disease (PID). These studies were relevant in trials assessing short-term or episodic symptom patterns and outcomes linked to inflammatory or irritative states.

For cUTI, well-controlled comparative clinical trials were utilized, focusing on adult patients with complex infections. Data show patterns related to the specific microbiological cure rates measured in the studied populations. In the case of PID, Ofloxacin was studied for its use in non-pregnant, sexually active women, often as part of a combination regimen with another antibacterial agent.


Evidence Gaps and Areas of Uncertainty

Research highlights what is still uncertain about Ofloxacin's clinical profile. The core body of evidence includes trials from several decades ago, and research examined under those conditions may not fully capture the patterns of evolving antimicrobial resistance. Furthermore, follow-up durations were limited, resulting in data for long-term outcomes remaining insufficient. In some indications, such as PID, the drug was studied in a combination regimen, making the independent contribution of Ofloxacin uncertain. Finally, the evidence quality varies across studies, requiring continuous research as the broader evidence landscape evolves.

Key Studies & References

  1. Infectious Diseases Society of America (IDSA) Guideline on Community-Acquired Pneumonia

Frequently Asked Questions (FAQ)

Common questions about Floxil (FAQ)

Q: How quickly does Floxil usually start to work?

A: Official pharmacological information indicates that Floxil, which contains ofloxacin, typically reaches its maximum concentration in the bloodstream one to two hours after an oral dose. This time point is important for systemic use, as it indicates when the highest level of the medicine is available to act against the infection.

Q: How long does the effect of one dose of Floxil last?

A: The duration of the medication's presence in the body is often described by its plasma half-life, which is about 4 to 5 hours in younger subjects. The half-life refers to the time it takes for the drug's concentration to decrease by half. This information helps inform the recommended dosing schedule.

Q: Is it okay to stop taking Floxil once I feel better?

A: Regulatory guidance describes the importance of taking the medication exactly as directed until the full course prescribed by a healthcare provider is completed. Even if symptoms have improved, stopping treatment early is not recommended. Premature discontinuation may be associated with incomplete elimination of the target bacteria.

Q: Why is it important to take the full course of Floxil?

A: The full prescribed duration is intended to support the complete elimination of susceptible bacteria. Official documents state that stopping the antibiotic course too soon increases the risk of the original infection returning. This practice also helps promote the reduction of drug-resistant bacteria.

Q: Does Floxil interact with common pain relievers like ibuprofen?

A: Official documents caution that the use of a quinolone, such as Floxil, with a type of pain reliever known as a nonsteroidal anti-inflammatory drug (NSAID), which includes ibuprofen, may increase the risk of central nervous system effects. This includes a reported increase in the risk of convulsive seizures.

Q: What happens if I forget to take a dose of Floxil?

A: Regulatory advice typically states that if a dose is missed, it can be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose is usually skipped. Official guidance emphasizes that extra medication should not be used to make up for a forgotten dose.

Q: Can I take Floxil if I have kidney issues?

A: Floxil can be used by patients with kidney issues, but official documents mandate caution. Since the drug is mainly eliminated through the kidneys, patients with significantly reduced kidney function require a specific dosage adjustment. This measure is used to prevent the medicine from accumulating too much in the body.

Q: How is Floxil typically eliminated from the body?

A: The medication is primarily cleared from the body through renal excretion, meaning it is passed out through the kidneys in urine. This pharmacokinetic fact is why regulatory information specifies that the dose may need to be adjusted for patients with impaired kidney function.

Q: What types of infections is Floxil most commonly prescribed for?

A: Floxil is officially indicated for the treatment of various bacterial infections. These include infections of the respiratory tract (such as community-acquired pneumonia), urinary tract infections, prostatitis, and pelvic inflammatory disease. The drug is prescribed only when these infections are caused by susceptible bacteria.

Q: What are the main points in the 'Who can and cannot use Floxil' section?

A: The key eligibility constraints highlighted in official documentation include a documented allergy to quinolone antibiotics and a history of certain central nervous system disorders or tendon problems related to prior quinolone use. Additionally, systemic use of Floxil is generally reserved for adults, meaning it is prohibited in children and growing adolescents.

Q: Are there any common foods or drinks that interact with Floxil?

A: Official drug interaction information focuses on products containing multivalent metal cations, which can bind to Floxil and stop it from being properly absorbed. This includes foods such as dairy products. Administration of the drug should be separated from these items by at least two hours.

Q: Can taking Floxil affect the results of lab tests?

A: Regulatory documents indicate that Floxil may be associated with disturbances in blood glucose, potentially affecting blood sugar readings. Additionally, in some cases, fluoroquinolones are noted in medical literature to potentially cause false positive results in urine screening tests for opiates.

Q: Can Floxil be taken with dairy products?

A: Official administration instructions recommend separation of Floxil from dairy products. While the oral tablets may be taken with non-dairy food, taking the medication at the same time as dairy, such as milk or yogurt, can significantly reduce the drug's absorption. Regulatory information suggests a separation of at least two hours.

Q: Does Floxil interact with caffeine?

A: Official information mentions that Floxil can cause Central Nervous System effects, such as anxiety and insomnia. Some medical literature suggests that caution regarding caffeine consumption may be warranted due to the potential for compounded Central Nervous System effects.

Q: Is there a generic version of Floxil available?

A: Yes, the active ingredient in Floxil is ofloxacin. According to regulatory records, ofloxacin is available in the United States and other regions from multiple manufacturers as a generic prescription drug.

Q: Are there different strengths or forms of Floxil?

A: Official documentation lists Floxil (ofloxacin) as being available in multiple forms for different uses. These include oral tablets in strengths such as 200 mg, 300 mg, and 400 mg, as well as an intravenous solution for systemic use and an ophthalmic solution for topical use in the eye.

Q: Does Floxil contain penicillin or sulfa?

A: No. Floxil does not contain ingredients from the penicillin or sulfa classes of antibiotics. Official chemical classification defines Floxil (ofloxacin) as a fluoroquinolone antibiotic, which is a purely synthetic compound.

Q: What should I do if I experience a skin rash while taking Floxil?

A: Regulatory information indicates that the appearance of a skin rash may be a sign of a serious reaction, including hypersensitivity. Official guidance describes that serious reactions often require immediate discontinuation of the medication and prompt medical attention.

Q: What if I accidentally take more Floxil than prescribed?

A: In cases of accidental ingestion of more Floxil than prescribed, regulatory documents describe that emergency medical attention may be necessary. Events that have been noted in cases of acute overdose are rare but include severe effects such as seizures or acute kidney failure.

Q: Is it common for people to have an allergic reaction to Floxil?

A: Allergic reactions and other hypersensitivity responses are noted in regulatory documents, but their incidence is generally reported in medical literature as being uncommon. This means these types of reactions are not reported in most instances of drug use.

Q: Is there any research about Floxil's use in children?

A: For systemic use (oral or intravenous), Floxil is contraindicated, or prohibited, in children and growing adolescents. However, official regulatory review has established the safety and use of the topical otic solution formulation for specific infections in pediatric patients starting at six months of age.

Q: Do studies show Floxil is effective for its stated uses?

A: Yes, regulatory approval of Floxil was supported by clinical trials. These studies examined outcomes such as clinical cure rates and microbiological eradication rates against susceptible bacteria. The positive findings led to the listing of the drug for its approved indications.

Q: Does research indicate Floxil causes resistance in bacteria?

A: Regulatory documents recommend that Floxil should only be used to treat infections strongly suspected or proven to be caused by susceptible bacteria. This measure is intended to support the reduction of drug-resistant bacteria and promote the continued effectiveness of the antibiotic.

Q: Is the long-term use of Floxil described in official documents?

A: Regulatory safety reviews have highlighted that some serious adverse effects associated with this class of antibiotics can be long-lasting. Additionally, clinical studies often have limited follow-up periods, meaning the core evidence body provides limited data on very long-term outcomes of use.

Q: How is the effectiveness of Floxil measured in clinical studies?

A: In clinical trials, effectiveness was measured using specific endpoints. These typically included the clinical cure or improvement rate, which looks at the resolution of symptoms, and the microbiological eradication rate, which checks for the elimination of the causative bacteria.

Q: Does taking Floxil affect my ability to drive or operate machinery?

A: Official guidance notes that due to the potential for side effects such as dizziness and lightheadedness, patients should consider refraining from activities such as driving or operating machinery until they are aware of the drug's effects on them.

Q: Is there a link between Floxil and changes in blood sugar?

A: Yes, official labeling includes a caution that the drug can be associated with disturbances in blood glucose levels, a condition referred to as dysglycemia. This includes the potential for both abnormally low (hypoglycemia) and high (hyperglycemia) blood sugar.

Q: Is it normal to feel dizzy after taking Floxil?

A: Dizziness is listed in regulatory documentation as an uncommon adverse reaction that has been reported in patients taking Floxil. The official labeling highlights this as a known, though not frequent, effect.

How should Floxil be stored and disposed of?

How to Store and Dispose of Floxil?

Floxil (ofloxacin) storage and disposal requirements are based on official regulatory documentation to maintain product quality and safety.

Official Storage Requirements

Storage Category Requirement
Temperature Store at controlled room temperature (e.g., 20 C to 25 C), unless otherwise specified on the product label.
Protection Keep the medication in its original container with the closure system intact to protect it from environmental factors.
Safety Keep this medication out of the reach of children and pets to prevent accidental ingestion.

Official Disposal Instructions

Unused or expired Floxil should be disposed of by following official guidelines. The preferred method is to participate in a drug take-back program. If one is not available, the medication may be mixed with an undesirable substance, sealed in a plastic bag, and placed in the household trash. Do not flush the medication down a toilet or drain unless the label explicitly states to do so.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Floxil found in:

A-Z Index: